HDL and Reverse Cholesterol Transport Biomarkers

Kayla A. Riggs, Anand K Rohatgi

Research output: Contribution to journalReview article

Abstract

High-density lipoprotein (HDL) is a protein-lipid nanoparticle that has predominately been characterized by its cholesterol concentration (HDL-C). Recent studies have challenged the presumed inverse association between HDL-C and cardiovascular events, suggesting a more U-shaped association. This has opened new opportunities to evaluate more novel measures of HDL metabolism, such as HDL particle number (HDL-P) and one of HDL's key functions, cholesterol efflux. Both HDL-P and cholesterol efflux are inversely associated with incident cardiovascular events and may perhaps be better targets for intervention. This review includes recent research on the emerging U-shaped association between HDL-C and cardiovascular events, recent observational studies related to HDL-P, and the effects of established and novel interventions on cholesterol efflux.

Original languageEnglish (US)
Pages (from-to)39-46
Number of pages8
JournalMethodist DeBakey cardiovascular journal
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

HDL Lipoproteins
HDL Cholesterol
Biomarkers
Cholesterol
Nanoparticles
Observational Studies
Lipids
Research
Proteins

Keywords

  • cholesterol efflux capacity
  • HDL
  • HDL-C
  • HDL-P
  • high-density lipoprotein

ASJC Scopus subject areas

  • Medicine(all)

Cite this

HDL and Reverse Cholesterol Transport Biomarkers. / Riggs, Kayla A.; Rohatgi, Anand K.

In: Methodist DeBakey cardiovascular journal, Vol. 15, No. 1, 01.01.2019, p. 39-46.

Research output: Contribution to journalReview article

@article{290f1ecf67f8412ca1a93efdd40bd716,
title = "HDL and Reverse Cholesterol Transport Biomarkers",
abstract = "High-density lipoprotein (HDL) is a protein-lipid nanoparticle that has predominately been characterized by its cholesterol concentration (HDL-C). Recent studies have challenged the presumed inverse association between HDL-C and cardiovascular events, suggesting a more U-shaped association. This has opened new opportunities to evaluate more novel measures of HDL metabolism, such as HDL particle number (HDL-P) and one of HDL's key functions, cholesterol efflux. Both HDL-P and cholesterol efflux are inversely associated with incident cardiovascular events and may perhaps be better targets for intervention. This review includes recent research on the emerging U-shaped association between HDL-C and cardiovascular events, recent observational studies related to HDL-P, and the effects of established and novel interventions on cholesterol efflux.",
keywords = "cholesterol efflux capacity, HDL, HDL-C, HDL-P, high-density lipoprotein",
author = "Riggs, {Kayla A.} and Rohatgi, {Anand K}",
year = "2019",
month = "1",
day = "1",
doi = "10.14797/mdcj-15-1-39",
language = "English (US)",
volume = "15",
pages = "39--46",
journal = "Methodist DeBakey cardiovascular journal",
issn = "1947-6094",
publisher = "Methodist DeBakey Heart & Vascular Center",
number = "1",

}

TY - JOUR

T1 - HDL and Reverse Cholesterol Transport Biomarkers

AU - Riggs, Kayla A.

AU - Rohatgi, Anand K

PY - 2019/1/1

Y1 - 2019/1/1

N2 - High-density lipoprotein (HDL) is a protein-lipid nanoparticle that has predominately been characterized by its cholesterol concentration (HDL-C). Recent studies have challenged the presumed inverse association between HDL-C and cardiovascular events, suggesting a more U-shaped association. This has opened new opportunities to evaluate more novel measures of HDL metabolism, such as HDL particle number (HDL-P) and one of HDL's key functions, cholesterol efflux. Both HDL-P and cholesterol efflux are inversely associated with incident cardiovascular events and may perhaps be better targets for intervention. This review includes recent research on the emerging U-shaped association between HDL-C and cardiovascular events, recent observational studies related to HDL-P, and the effects of established and novel interventions on cholesterol efflux.

AB - High-density lipoprotein (HDL) is a protein-lipid nanoparticle that has predominately been characterized by its cholesterol concentration (HDL-C). Recent studies have challenged the presumed inverse association between HDL-C and cardiovascular events, suggesting a more U-shaped association. This has opened new opportunities to evaluate more novel measures of HDL metabolism, such as HDL particle number (HDL-P) and one of HDL's key functions, cholesterol efflux. Both HDL-P and cholesterol efflux are inversely associated with incident cardiovascular events and may perhaps be better targets for intervention. This review includes recent research on the emerging U-shaped association between HDL-C and cardiovascular events, recent observational studies related to HDL-P, and the effects of established and novel interventions on cholesterol efflux.

KW - cholesterol efflux capacity

KW - HDL

KW - HDL-C

KW - HDL-P

KW - high-density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=85065591024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065591024&partnerID=8YFLogxK

U2 - 10.14797/mdcj-15-1-39

DO - 10.14797/mdcj-15-1-39

M3 - Review article

VL - 15

SP - 39

EP - 46

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

SN - 1947-6094

IS - 1

ER -